Heart Transplant

Cardiac Lymphatics Predict Survival After Heart Transplantation 2026 Heart Disease and Stroke Statistics Letter by He et al Regarding Article, “Targeting uPARAP Modifies Lymphatic Vessel Architecture and Attenuates Lymphedema” Impact of Peak Donor Troponin and Donor Troponin Trends on Pediatric Heart Transplant Outcomes Identification of Heart Transplant Rejection Subtypes With Circulating MicroRNAs When the Target Is Not the Driver: Rethinking LDL in Cardiac Allograft Vasculopathy Why We Must Rethink Kidney Transplantation as a Cardiovascular Risk–Reducing Intervention in Kidney Failure Predictors of Response to Cardiac Resynchronization Therapy in Pediatric Patients and Patients With Congenital Heart Disease Cell-Free DNA Profiles End-Organ Injury and Predicts Outcomes in Advanced Heart Failure With Left Ventricular Assist Device Implantation Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial